The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation

Janis M. Taube, Güray Aktürk, Michael Angelo, +24

Journal for ImmunoTherapy of Cancer

Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial

Suzanne L. Topalian, Shailender Bhatia, Asim Amin, +21

Journal of Clinical Oncology

Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade

Sneha Berry, Nicolás A. Giraldo, Benjamin Green, +34

Science

Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab

Nicolás A. Giraldo, Peter Nguyen, Elizabeth L. Engle, +24

Journal for ImmunoTherapy of Cancer

Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir

Claudia R. Avalos, Celina Monteiro Abreu, Suzanne E. Queen, +13

mBio

Multi-institutional TSA-amplified Multiplexed Immunofluorescence Reproducibility Evaluation (MITRE) Study

Janis M. Taube, Kristin Roman, Elizabeth L. Engle, +13

Journal for ImmunoTherapy of Cancer

A Murine Viral Outgrowth Assay to Detect Residual HIV Type 1 in Patients With Undetectable Viral Loads

Kelly A. Metcalf Pate, Christopher W. Pohlmeyer, Victoria E. Walker-Sperling, +18

The Journal of Infectious Diseases

Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma

Daniel Shu, Won Jin Ho, Luciane T. Kagohara, +36

Nature Immunology

Cancer ImmunosurveillanceHepatologyHepatocellular CarcinomaImmunologyPathology +5

Intratumoral Adaptive Immunosuppression and Type 17 Immunity in Mismatch Repair Proficient Colorectal Tumors

Nicolás J. Llosa, Brandon Luber, Ada Tam, +21

Clinical Cancer Research

Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial

Evanthia T. Roussos Torres, Won Jin Ho, Ludmila Danilova, +24

Nature Cancer

Breast OncologyMedicineClinical TrialsGynecologyPhase Ib Trial +7